GlassScriptPhysician profile
Paul J Lee
NPI 1376047332
$43,062.31
in general payments reported to CMS, 2019-2025
19 companies · $15K in 2025
The $15K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $436 · 2022: $1,349 · 2023: $6,847 · 2024: $19K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $22K · Food and Beverage: $9,388 · Grant: $8,515 · Education: $1,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $22,203.12 |
| Food and Beverage | $9,387.63 |
| Grant | $8,515.47 |
| Education | $1,171.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15,904.49 | 2021-2025 | Ensite, Gallant, Ensite Precision |
| Medtronic, INC. | $9,695.65 | 2023-2025 | Pulseselect, Arctic Front Advance |
| Boston Scientific Corporation | $7,401.67 | 2021-2025 | Versacross Access Solution, Farapulse, Watchman Flx |
| Medical Device Business Services, INC. | $3,708.88 | 2024 | Carto 3 |
| Biosense Webster, INC. | $1,964.61 | 2024-2025 | Carto 3, Qdot Micro Catheter |
| Philips North America LLC | $1,328.55 | 2025 | Igt Devices Undivided, Lm Undivided |
| Atricure, INC. | $853.19 | 2023 | |
| Inari Medical, INC. | $849.91 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Impulse Dynamics (USA) INC. | $389.43 | 2024-2025 | Optimizer |
| Biotronik INC. | $290.87 | 2021-2025 | Acticor 7 Vr-T Dx |
| Sanofi-Aventis U.S. LLC | $187.81 | 2022 | |
| Cardiva Medical, INC. | $144.94 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Amgen INC. | $98.87 | 2024-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $94.25 | 2023 | Camzyos |
| Edwards Lifesciences Corporation | $45.44 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $39.58 | 2022-2023 | Impella |
| Getinge USA Sales, LLC | $35.82 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $14.85 | 2024 | Farxiga |
| Instylla, INC. | $13.50 | 2024 | Instylla Delivery Kit, Instylla Microcatheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.